Transplantation of Ovarian Cortex to Restore Fertility

NCT ID: NCT01442584

Last Updated: 2011-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-07-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ovarian transplantation has been shown to restore fertility.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators transplant ovarian cortex previously collected from the patient prior to cancer treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

fertility restoration by transplantation

fertility restoration by transplantation of ovarian cortex slivers that were cryopreserved prior to chemotherapy

Group Type EXPERIMENTAL

ovarian transplantation

Intervention Type PROCEDURE

ovarian transplantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ovarian transplantation

ovarian transplantation

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

frozen thawed ovarian cortex transplantation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who froze ovarian tissue

Exclusion Criteria

* malignant cells in ovary
Minimum Eligible Age

20 Years

Maximum Eligible Age

54 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hadassah Medical Organization

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hadassah Medical Organization

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ariel Revel, MD

Role: STUDY_CHAIR

Hadassah

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hadassah

Jerusalem, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ariel revel, md

Role: CONTACT

97226777111 ext. 74399

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

ariel revel, md

Role: primary

97226777111 ext. 74399

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ovarian transplant- HMO-CTIL

Identifier Type: -

Identifier Source: org_study_id